Blood-repellent materials: A new tactic medical implants

Blood-repellent materials: A new tactic to medical implants

11:55 AM, 19th January 2017
Blood-repellent materials
Blood, plasma and water droplets beading on a superomniphobic surface. CSU researchers have created a superhemophobic titanium surface, repellent to blood, that has potential applications for biocompatible medical devices.

FORT COLLINS, US: Medical implants like stents, catheters and tubing introduce risk for blood clotting and infection – a perpetual problem for many patients.

Colorado State University (CSU) engineers offer a potential solution: A specially grown, “superhemophobic” titanium surface that’s extremely repellent to blood. The material could form the basis for surgical implants with a lower risk of rejection by the body.

Biomedical, materials approaches

It’s an outside-the-box innovation achieved at the intersection of two disciplines: biomedical engineering and materials science.

The work is published in the journal Advanced Healthcare Materials, is a collaboration between the labs of Arun Kota, assistant professor of mechanical engineering and biomedical engineering; and Ketul Popat, associate professor in the same departments.

Kota, an expert in a novel, “superomniphobic” materials that repel virtually any liquid, joined forces with Popat, an innovator in tissue engineering and bio-compatible materials. Starting with sheets of titanium, commonly used for medical devices, their labs grew chemically altered surfaces that act as perfect barriers between the titanium and blood. Their teams conducted experiments showing very low levels of platelet adhesion, a biological process that leads to blood clotting and eventual rejection of a foreign material.

Chemical compatibility

A material “phobic” (repellent) to blood might seem counterintuitive, the researchers say, as often biomedical scientists use materials “philic” (with affinity) to blood to make them biologically compatible.

“What we are doing is the exact opposite,” Kota said. “We are taking a material that blood hates to come in contact with, in order to make it compatible with blood.”

The key innovation is that the surface is so repellent, that blood is tricked into believing there’s virtually no foreign material there at all.

The undesirable interaction of blood with foreign materials is an ongoing problem in medical research, Popat said. Over time, stents can form clots, obstructions, and lead to heart attacks or embolisms. Often patients need blood-thinning medications for the rest of their lives – and the drugs aren’t foolproof.

“The reason blood clots are because it finds cells in the blood to go to and attach,” Popat said. “Normally, blood flows in vessels. If we can design materials where blood barely contacts the surface, there is virtually no chance of clotting, which is a coordinated set of events. Here, we’re targeting the prevention of the first set of events.”

The researchers analysed variations of titanium surfaces, including different textures and chemistries, and they compared the extent of platelet adhesion and activation. Fluorinated nanotubes offered the best protection against clotting, and they plan to conduct follow-up experiments.

Growing a surface and testing it in the lab is only the beginning, the researchers say. They want to continue examining other clotting factors, and eventually, to test real medical devices.

© Colorado State University News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


LyondellBasell announces changes in leadership management

HOUSTON, US/ LONDON, UK: LyondellBasell Industries NV announced a planned executive leadership change. After 7 years with LyondellBasell, Kevin Brown ...

Read more
Breakthrough in making plastic from pine trees

BATH, UK: Most current plastics are made from oil, which is unsustainable. But, researchers from the Centre for Sustainable Chemical Technologies ...

Read more
ExxonMobil, Synthetic Genomics extend algae biofuels research agreement

LA JOLLA, US: ExxonMobil Corporation and Synthetic Genomics Inc have extended their agreement to conduct joint research into advanced algae biofuels, ...

Read more
Merck opens new meglumine production facility in Spain

DARMSTADT, GERMANY: Merck has opened a meglumine manufacturing facility in Mollet des Valles, Spain. Meglumine is an amino sugar derived from glucose. ...

Read more
Sabic’s polycarbonate resins used in new-generation MPVs

SITTARD, THE NETHERLANDS: SAIC General Motors (SGM) has launched in China its new-generation Buick GL8 and GL8 Avenir luxury multi-purpose vehicles (M ...

Read more
IFF completes acquisition of fragrance company in US

NEW YORK, US: International Flavors & Fragrances Inc (IFF) said that it has successfully completed the previously announced acquisition of Fragran ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X